Federal Register / Vol. 70, No. 170 / Friday, September 2, 2005 / Notices 52395 

VII. Agency Contacts 

For assistance on administrative and 

budgetary requirements, please contact: 

Ms. Karen Campbell, Director, Office of 

Grants Management, OPHS, HHS 1101 

Wootton Parkway, Suite 550, Rockville, 

MD 20852, phone (240) 453–8822. 

For assistance with questions 

regarding program requirements, please 

contact: Dr. Amar Bhat, Asia-Pacific 

Division, Office of Global Health Affairs, 

Office of the Secretary, Department of 

Health and Human Services, 5600 

Fishers Lane, Suite 18–101, Rockville, 

MD 20857. Phone Number: 301–443–

1410. 

VIII. Tips for Writing a Strong 

Application 

Include DUNS Number. You must 

include a DUNS Number to have your 

application reviewed. Applications will 

not be reviewed without a DUNS 

number. To obtain a DUNS number, 

access www.dunandbradstreet.com or 

call 1–866–705–5711. Please include the 

DUNS number next to the OMB 

Approval Number on the application 

face page. 

Keep your audience in mind. 

Reviewers will use only the information 

contained in the application to assess 

the application. Be sure the application 

and responses to the program 

requirements and expectations are 

complete and clearly written. Do not 

assume that reviewers are familiar with 

the applicant organization. Keep the 

review criteria in mind when writing 

the application. 

Start preparing the application early. 

Allow plenty of time to gather required 

information from various sources. 

Follow the instructions in this 

guidance carefully. Place all information 

in the order requested in the guidance. 

If the information is not placed in the 

requested order, you may receive a 

lower score. 

Be brief, concise, and clear. Make 

your points understandable. Provide 

accurate and honest information, 

including candid accounts of problems 

and realistic plans to address them. If 

any required information or data is 

omitted, explain why. Make sure the 

information provided in each table, 

chart, attachment, etc., is consistent 

with the proposal narrative and 

information in other tables. 

Be organized and logical. Many 

applications fail to receive a high score 

because the reviewers cannot follow the 

thought process of the applicant or 

because parts of the application do not 

fit together. 

Be careful in the use of appendices. 

Do not use the appendices for 

information that is required in the body 

of the application. Be sure to crossreference all tables and attachments 

located in the appendices to the 

appropriate text in the application. 

Carefully proofread the application. 

Misspellings and grammatical errors 

will impede reviewers in understanding 

the application. Be sure pages are 

numbered (including appendices) and 

that page limits are followed. Limit the 

use of abbreviations and acronyms, and 

define each one at its first use and 

periodically throughout application. 

Dated: August 26, 2005. 

Mary Lou Valdez, 

Deputy Director for Policy, Office of Global 

Health Affairs. 

Cristina V. Beato, 

Acting Assistant Secretary for Health, Office 

of Public Health and Science. 

[FR Doc. 05–17546 Filed 9–1–05; 8:45 am] 

BILLING CODE 4150–38–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Federal Guidelines for Requesting, 

Stockpiling, Distributing Potassium 

Iodide (KI) From the Strategic National 

Stockpile (SNS); Correction 

AGENCY: Office of Public Health 

Emergency Preparedness (OPHEP), 

HHS. 

SUMMARY: This document corrects the 

notice that appeared in the Federal 

Register on August 29, 2005, (70 FR 

51065), entitled ‘‘Federal Guidelines for 

Requesting, Stockpiling, Distributing 

Potassium Iodide (KI) From the Strategic 

National Stockpile (SNS)’. 

We inadvertently omitted the DATES

section of the notice to inform the 

public of how long we will be receiving 

comments. 

We are adding the DATES section to 

read as follows: 

DATES: Submit comments on or before 

November 1, 2005. 

Robert G. Claypool, 

Deputy Assistant Secretary, Office of Public, 

Health Emergency Preparedness. 

[FR Doc. 05–17556 Filed 9–1–05; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Program Announcement DP05–133] 

Mind/Body Research and Chronic 

Disease Conditions; Notice of Intent To 

Fund a Sole Source Award 

A. Purpose 

The Centers for Disease Control and 

Prevention (CDC) announces the intent 

to fund fiscal year (FY) 2005 funds for 

a grant program to support research on 

the impact and effectiveness of 

relaxation and stress reduction on 

chronic health conditions. This 

announcement will build on research 

currently being conducted in this area 

by the Beth Israel Deaconess Medical 

Center (BIDMC), Mind/Body Medical 

Institute (MBMI). The results from this 

study will continue to generate new 

knowledge on the physiologic 

mechanisms of the relaxation response, 

mechanisms of acute changes, and 

identification of those most likely to 

benefit in a specific clinical model. 

The Catalog of Federal Domestic 

Assistance number for this program is 

93.283. 

B. Eligible Applicant 

Assistance will be provided only to 

the Beth Israel Deaconess Medical 

Center (BIDMC), Mind/Body Medical 

Institute (MBMI), Harvard Medical 

School, 824 Boylston Street, Chestnut 

Hill, MA 02467. No other applications 

will be solicited. 

The BIDMC, MBMI is specifically 

referenced in the House of 

Representatives 2nd Session Conference 

Report 108–792. Page 1161 of the report 

states: ‘‘Within amounts provided for 

Community Health Promotion: * * * 

$1,974,000 is for the Mind-Body 

Institute in Boston, Massachusetts to 

continue practice-based assessments, 

identification, and study of promising 

and heavily-used mind/body practices.’’

The BIDMC, MBMI is a non-profit 

scientific and educational organization 

dedicated to the study of mind/body 

interactions, including the relaxation 

response. The institute uses its expertise 

to enhance the recognition and 

understanding of mind/body medicine’s 

role in the practice of medicine to foster 

and expand the uses of mind/body 

interaction in health care and other 

appropriate settings, thereby advancing 

health and well-being throughout the 

world. Today over 9,000 patients 

throughout the United States participate 

in the institutes clinical programs. 

52396 Federal Register / Vol. 70, No. 170 / Friday, September 2, 2005 / Notices 

The MBMI is the foundation of mind/ 

body medicine as practiced at the 

BIDMC, MBMI. It is based on the work 

of Herbert Benson, MD and colleagues at 

Harvard Medical School. Their 

pioneering research led to the definition 

of the relaxation response. The BIDMC, 

MBMI trains health care professionals 

from the U.S. and around the world in 

their highly successful clinical 

techniques. 

The mission of the BIDMC, MBMI, its 

long history of research in relaxation 

response, and the institution’s extensive 

network of resources make it highly 

probable that the BIDMC, MBMI will 

successfully achieve the activities 

identified in Section 1 of this RFA; 

therefore, it is the only eligible 

organization to conduct the research 

supported by this RFA. 

C. Funding 

Approximately $1,916,915 is available 

in FY 2005 to fund this award 

September 30, 2005 and will be made 

for a 12-month budget period within a 

project period of up to three years. 

Funding estimates may change. 

D. Where To Obtain Additional 

Information 

For general comments or questions 

about this announcement, contact: 

Technical Information Management, 

CDC Procurement and Grants Office, 

2920 Brandywine Road, Atlanta, GA 

30341–4146, Telephone: 770–488–2700. 

For technical questions about this 

program, contact: Brenda Colley Gilbert, 

Project Officer, 4770 Buford Highway 

N.E., Mailstop K–92, Atlanta, GA 30341, 

Telephone: 770–488–8390, E-mail: 

BColleyGilbert@cdc.gov. 

Dated: August 29, 2005. 

William P. Nichols, 

Director, Procurement and Grants Office, 

Centers for Disease Control and Prevention. 

[FR Doc. 05–17492 Filed 9–1–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Request for Application (RFA) AA084] 

Enhancement and Integration of Health 

Sector HIV/AIDS Strategic Information 

into the National Multi-Sectoral HIV/ 

AIDS Monitoring and Evaluation 

System of the United Republic of 

Tanzania as Part of the President’s 

Emergency Plan for AIDS Relief; 

Notice of Intent To Fund Limited 

Eligibility Award 

A. Purpose 

The Centers for Disease Control and 

Prevention (CDC) announces the intent 

to award fiscal year (FY) 2005 funds for 

a cooperative agreement program to 

enhance integration of health-sector 

HIV/AIDS strategic information into the 

national multi-sectoral HIV/AIDS 

database linked to the Country Response 

Information System (CRIS) in the United 

Republic of Tanzania. 

The Catalog of Federal Domestic 

Assistance number for this program is 

93.067. 

B. Eligible Applicant 

Assistance will only be provided to 

the Tanzania AIDS Commission 

(TACAIDS) and the Zanzibar AIDS 

Commission (ZAC). No other 

applications are solicited. 

TACAIDS and ZAC are currently the 

only appropriate and qualified 

organizations to conduct a specific set of 

activities to support the enhancement 

and integration of health sector HIV/ 

AIDS strategic information into the 

national multi-sectoral HIV/AIDS M&E 

system in the United Republic of 

Tanzania for the following reasons: 

1. TACAIDS and ZAC are uniquely 

positioned, in terms of legal authority, 

ability, and credibility among 

Tanzanian citizens, to coordinate the 

implementation of zonal initiatives for 

HIV/AIDS prevention, treatment, and 

care. 

2. TACAIDS and ZAC have developed 

national HIV/AIDS policies; a national 

multi-sectoral HIV/AIDS strategic 

framework, and strategic plans for 

enhancing national systems for 

collection of strategic information and 

M&E of HIV/AIDS in Tanzania, which 

allows TACAIDS and ZAC to 

immediately become engaged in the 

activities listed in this announcement. 

3. The purpose of the announcement 

is to build upon the existing framework 

of health policy and programming that 

TACAIDS and ZAC have initiated. 

4. TACAIDS and ZAC have a mandate 

under the Tanzanian Constitution to 

coordinate multi-sectoral activities 

necessary for the national response to 

HIV/AIDS. An Act of Parliament 

mandates TACAIDS and ZAC to 

monitor and evaluate multi-sectoral 

HIV/AIDS activities in the United 

Republic of Tanzania. 

C. Funding 

Approximately $500,000 is available 

in FY 2005 to fund this award to the two 

identified organizations. It is expected 

that the awards will begin on or before 

October 15, 2005, and will be made for 

a 12-month budget period within a 

project period of up to four years. 

Funding estimates may change. 

D. Where To Obtain Additional 

Information 

For general comments or questions 

about this announcement, contact: 

Technical Information Management, 

Procurement and Grants Office, Centers 

for Disease Control and Prevention 

(CDC), 2920 Brandywine Road, Atlanta, 

GA 30341–4146, Telephone: 770–488–

2700. 

For program technical assistance, 

contact: Cecil Threat, Project Officer, 

Global AIDS Program, c/o American 

Embassy-HHS/CDC, 2140 Dar es Salaam 

Place, Washington, DC 20521–2140, 

Telephone: 255 22 212 1407, Cellphone: 

255 744 222986, Fax: 255 22 212 1462. 

E-mail: Cthreat@cdc.gov. 

For financial, grants management, or 

budget assistance, contact: Diane 

Flournoy, Grants Management 

Specialist, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention (CDC), 2920 Brandywine 

Road, Atlanta, GA 30341, Telephone: 

770–488–2072, E-mail: 

dflournoy@cdc.gov. 

Dated: August 29, 2005. 

William P. Nichols, 

Director, Procurement and Grants Office, 

Centers for Disease Control and Prevention. 

[FR Doc. 05–17491 Filed 9–1–05; 8:45 am] 

BILLING CODE 4163–18–P